本文已被：浏览 1146次 下载 3次
中文摘要: 目的 总结射频消融术治疗子宫腺肌瘤的临床经验。方法 选取行射频消融术治疗子宫腺肌瘤患者72例，比较术前、术后各复诊点腺肌瘤体积变化、痛经程度和月经血量改变，观察术后并发症发生率。结果 射频消融术后子宫腺肌瘤体积缩小，术后1、3、6、12月缩小率分别为（26.49±0.20）％、（45.42±0.32）％、（83.67±0.34）％、（84.08±0.25）％；与术前比较，术后痛经评分降低、月经量减少，均有统计学意义（P＜0.05，P＜0.01）。术后发热、阴道流血、疼痛等并发症发生率15.28%。结论 射频消融术治疗子宫腺肌瘤后，子宫腺肌瘤体积明显缩小，临床效果显著，并发症低，可以作为微创治疗子宫腺肌瘤的方法。
Abstract:Objective To summarize the clinical experience of using radiofrequency ablation (RFA) in the treatment of adenomyoma. Methods A total of 72 patients with adenomyoma who received RFA were selected. The changes of adenomyoma size, dysmenorrheal severity and menstrual blood volume at each reexamination time point were compared before and after operation, and the rates of postoperative complications were observed. Results After RFA, the size of adenomyoma shrunk, with shrinking rates at postoperative 1, 3, 6 and 12 months were (26.49±0.20)%, (45.42±0.32) %, (83.67±0.34) % and (84.08±0.25)%, respectively. Dysmenorrheal score and menstrual blood volume decreased after operation than before, and there were significant differences (P<0.05, P<0.01). The total postoperative occurrence rate of complications like fever, vaginal bleeding and pain was 15.28%. Conclusion After operation, the size of adenomyoma decreases notably, clinical efficacy is excellent and the total rate of complications is low, indicating that RFA can be used a non-invasive method for the treatment of adenomyoma.
文章编号：3201712016 中图分类号：R1-9 文献标志码：
基金项目:
引用文本：